rs115005114

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000174.5(GP9):​c.*7C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00725 in 1,534,322 control chromosomes in the GnomAD database, including 301 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.027 ( 151 hom., cov: 33)
Exomes 𝑓: 0.0051 ( 150 hom. )

Consequence

GP9
NM_000174.5 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.250

Publications

1 publications found
Variant links:
Genes affected
GP9 (HGNC:4444): (glycoprotein IX platelet) This gene encodes a small membrane glycoprotein found on the surface of human platelets. It forms a 1-to-1 noncovalent complex with glycoprotein Ib, a platelet surface membrane glycoprotein complex that functions as a receptor for von Willebrand factor. The complete receptor complex includes noncovalent association of the alpha and beta subunits with the protein encoded by this gene and platelet glycoprotein V. Defects in this gene are a cause of Bernard-Soulier syndrome, also known as giant platelet disease. These patients have unusually large platelets and have a clinical bleeding tendency. [provided by RefSeq, Oct 2008]
GP9 Gene-Disease associations (from GenCC):
  • Bernard-Soulier syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0785 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GP9NM_000174.5 linkc.*7C>T 3_prime_UTR_variant Exon 3 of 3 ENST00000307395.5 NP_000165.1 P14770
GP9XM_047447997.1 linkc.*7C>T 3_prime_UTR_variant Exon 2 of 2 XP_047303953.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GP9ENST00000307395.5 linkc.*7C>T 3_prime_UTR_variant Exon 3 of 3 1 NM_000174.5 ENSP00000303942.4 P14770

Frequencies

GnomAD3 genomes
AF:
0.0269
AC:
4093
AN:
152118
Hom.:
151
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0811
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.0198
Gnomad ASJ
AF:
0.0389
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00281
Gnomad OTH
AF:
0.0292
GnomAD2 exomes
AF:
0.00994
AC:
1397
AN:
140486
AF XY:
0.00837
show subpopulations
Gnomad AFR exome
AF:
0.0841
Gnomad AMR exome
AF:
0.0117
Gnomad ASJ exome
AF:
0.0418
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00327
Gnomad OTH exome
AF:
0.0132
GnomAD4 exome
AF:
0.00509
AC:
7030
AN:
1382086
Hom.:
150
Cov.:
29
AF XY:
0.00487
AC XY:
3315
AN XY:
681206
show subpopulations
African (AFR)
AF:
0.0800
AC:
2495
AN:
31182
American (AMR)
AF:
0.0126
AC:
445
AN:
35186
Ashkenazi Jewish (ASJ)
AF:
0.0435
AC:
1086
AN:
24962
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35670
South Asian (SAS)
AF:
0.00112
AC:
88
AN:
78766
European-Finnish (FIN)
AF:
0.0000211
AC:
1
AN:
47284
Middle Eastern (MID)
AF:
0.0246
AC:
100
AN:
4060
European-Non Finnish (NFE)
AF:
0.00199
AC:
2123
AN:
1067848
Other (OTH)
AF:
0.0121
AC:
692
AN:
57128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
395
790
1186
1581
1976
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0269
AC:
4090
AN:
152236
Hom.:
151
Cov.:
33
AF XY:
0.0265
AC XY:
1974
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0808
AC:
3355
AN:
41526
American (AMR)
AF:
0.0198
AC:
303
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0389
AC:
135
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.00281
AC:
191
AN:
68006
Other (OTH)
AF:
0.0289
AC:
61
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
195
390
584
779
974
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0114
Hom.:
15
Bravo
AF:
0.0301
Asia WGS
AF:
0.00577
AC:
20
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bernard Soulier syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.72
DANN
Benign
0.82
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115005114; hg19: chr3-128781123; API